Evidence map›Paper›PMID 33266494›Full record

ArticleInternational journal of molecular sciences2020

Dehydroxyhispolon Methyl Ether, A Hispolon Derivative, Inhibits WNT/β-Catenin Signaling to Elicit Human Colorectal Carcinoma Cell Apoptosis.

Hueng-Chuen Fan, Ya-Chu Hsieh, Li-Hsuan Li, Ching-Chin Chang, Karolína Janoušková, Modukuri V Ramani, Gottumukkala V Subbaraju, Kur-Ta Cheng, Chia-Che Chang

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 36 citations in OpenAlex.

  1. Journal of Cancer · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. 6-Biomedicines · 2024
    Article
  8. Pharmaceuticals (Basel, Switzerland) · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. International journal of molecular sciences · 2023
    Article
  13. Article
  14. Review
  15. Article
  16. Marine SpongePharmaceuticals (Basel, Switzerland) · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Hueng-Chuen FanDepartment of Pediatrics, Department of Medical Research, Tungs' Taichung Metroharbor Hospital, Wuchi, Taichung 43503, Taiwan.ORCID 0000-0003-3485-7558
Ya-Chu HsiehPh.D. Program in Tissue Engineering and Regenerative Medicine, National Chung Hsing University, Taichung 40227, Taiwan.
Li-Hsuan LiPh.D. Program in Tissue Engineering and Regenerative Medicine, National Chung Hsing University, Taichung 40227, Taiwan.
Ching-Chin ChangInstitute of Biomedical Sciences, National Chung Hsing University, Taichung 40227, Taiwan.
Karolína JanouškováInstitute of Biomedical Sciences, National Chung Hsing University, Taichung 40227, Taiwan.ORCID 0000-0003-4181-3801
Modukuri V RamaniDepartment of Organic Chemistry, Andhra University, Visakhapatnam 530 003, India.
Gottumukkala V SubbarajuDepartment of Organic Chemistry, Andhra University, Visakhapatnam 530 003, India.
Kur-Ta ChengDepartment of Biochemistry and Molecular Cell Biology, Taipei Medical University, Taipei 11031, Taiwan.
Chia-Che ChangPh.D. Program in Translational Medicine, National Chung Hsing University, Taichung 40227, Taiwan.ORCID 0000-0003-3509-3713
Asia University · TWAndhra University · INNational Chung Hsing University · TW

Funding

Tungs' Taichung MetroHarbor Hospital TTMHH-108R0010
6 · The paper itself

Abstract

Colorectal cancer (CRC) is the fourth leading cause of cancer mortality worldwide. Aberrant activation of WNT/β-catenin signaling present in the vast majority of CRC cases is indispensable for CRC initiation and progression, and thus is a promising target for CRC therapeutics. Hispolon is a fungal-derived polyphenol with a pronounced anticancer effect. Several hispolon derivatives, including dehydroxyhispolon methyl ether (DHME), have been chemically synthesized for developing lead molecules with stronger anticancer activity. Herein, a DHME-elicited anti-CRC effect with the underlying mechanism is reported for the first time. Specifically, DHME was found to be more cytotoxic than hispolon against a panel of human CRC cell lines, while exerting limited toxicity to normal human colon cell line CCD 841 CoN. Additionally, the cytotoxic effect of DHME appeared to rely on inducing apoptosis. This notion was evidenced by DHME-elicited upregulation of poly (ADP-ribose) polymerase (PARP) cleavage and a cell population positively stained by annexin V, alongside the downregulation of antiapoptotic B-cell lymphoma 2 (BCL-2), whereas the blockade of apoptosis by the pan-caspase inhibitor z-VAD-fmk attenuated DHME-induced cytotoxicity. Further mechanistic inquiry revealed the inhibitory action of DHME on β-catenin-mediated, T-cell factor (TCF)-dependent transcription activity, suggesting that DHME thwarted the aberrantly active WNT/β-catenin signaling in CRC cells. Notably, ectopic expression of a dominant-active β-catenin mutant (∆N90-β-catenin) abolished DHME-induced apoptosis while also restoring BCL-2 expression. Collectively, we identified DHME as a selective proapoptotic agent against CRC cells, exerting more potent cytotoxicity than hispolon, and provoking CRC cell apoptosis via suppression of the WNT/β-catenin signaling axis.

Indexed as

ApoptosisAntineoplastic AgentsBasidiomycotaCell Line, TumorColorectal NeoplasmsGene Expression Regulation, NeoplasticHCT116 CellsHumansPoly(ADP-ribose) PolymerasesProto-Oncogene Proteins c-bcl-2Wnt Signaling PathwayAntineoplastic AgentsPoly(ADP-ribose) PolymerasesProto-Oncogene Proteins c-bcl-2colorectal cancerdehydroxyhispolon methyl etherhispolonhispolon derivativesPhellinus linteusWNT/β-catenin

Identifiers

PMID33266494
PMCPMC7700694
OpenAlexW3108835271

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.